T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
Zhejiang University
Zhejiang University
University of Alabama at Birmingham
University of Alabama at Birmingham
China Medical University Hospital
M.D. Anderson Cancer Center
University of Alabama at Birmingham
West China Hospital
M.D. Anderson Cancer Center
University Health Network, Toronto
University Health Network, Toronto
Memorial Sloan Kettering Cancer Center
Institut BergoniƩ
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Maryland, Baltimore
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of California, Irvine
University Hospital, Brest
Tulane University
H. Lee Moffitt Cancer Center and Research Institute
Vanderbilt University Medical Center
Ruijin Hospital
University of Castilla-La Mancha
Ruijin Hospital
University of California, Irvine
University of Rochester
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Centre Leon Berard
AquĆ Nadie Se Rinde I.A.P.
Royal Marsden NHS Foundation Trust
University Hospital, Strasbourg, France
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Nemours Children's Clinic
M.D. Anderson Cancer Center
Northwestern University
King's College London
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
University Medical Center Groningen
Institut BergoniƩ
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
University Medical Center Groningen
Jonsson Comprehensive Cancer Center